Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Non-GAAP Net Income Attributable to Teva by Quarter
Non-GAAP Net Income Attributable to Teva ($M)
Teva Pharmaceutical Industries Non-GAAP Net Income Attributable to Teva: $1,013M in Q3 2026, up 11.3% from a year earlier.
Where the Q3 2026 figure comes from
“|| Non-GAAP net income attributable to Teva | $ | 1,013 | 910 | $ | 1,655 | 2,281”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Non-GAAP Net Income Attributable to Teva ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-net-inc
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?